Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	96.29	65.90	33.57
Graham Fair Price	770.60	3.27	0.38
PEG	-99.99	< 0.005	-9.80
Price/Book	-3.25	1.47	1.52
Price/Cash Flow	72.96	22.69	13.12
Prices/Earnings	-98.63	10.73	784.33
Price/Sales	-15.04	1.93	2.28
Price/FCF	72.96	22.69	13.12
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-9.49	0.36	0.40
Operating Margin	103227.28	0.05	< 0.005
ROA	7369.52	< 0.005	< 0.005
ROE	< 0.005	0.03	6969.44
ROIC	< 0.005	0.02	60385.53
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.07	-66.20
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.99	1217.46	123271.93
EPS QOQ	-0.80	75.47	9333.82
FCF QOQ	-0.57	-0.42	26.59
Revenue QOQ	-0.07	0.18	156.58
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	42.76	30.11	-29.60
Days Sales Outstanding (DSO)	7.49	8.09	8.11
Inventory Turnover	2.10	2.99	42.05
Debt/Capitalization	0.42	0.41	-3.74
Quick Ratio	0.70	0.64	-9.20
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.60	3.73	3.54
Cash	6.86	5.90	-14.10
Capex	-0.12	-0.13	-0.90
Free Cash Flow	0.42	0.24	-42.08
Revenue	2.40	2.83	17.92
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.80	0.79	-0.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.28	37.81	96.07
Naive Interpretation	Member

06 - Financial Health · Bad

Rating